 |
 |
 |
Search IPO GMP:
Sai Parenteral's IPO GMP
Sai Parenteral's IPO is a Mainboard IPO, the company will raise up to 408 crore 78 lakh 88 thousand 8 hundred ninety-six rupees for 1,04,28,288 shares. The IPO comprises a fresh issue of 72,70,408 shares (aggregating up to 284 crore 99 lakh 99 thousand 9 hundred thirty-six rupees), and an offer for sale (OFS) of 31,57,880 shares (aggregating up to 123 crore 78 lakh 88 thousand 9 hundred sixty rupees).
| Sai Parenteral's IPO GMP (Grey Market Premium) | |
| Premium From IPO Cut-off Price | |
| IPO Price Band | ₹372 to ₹392 per share |
Sai Parenteral's IPO GMP (Grey Market Premium) Today
Visit us daily to get the latest update on Sai Parenteral's IPO GMP. IPO GMP started, and here you can get the latest update of Sai Parenteral's IPO GMP.
Sai Parenteral's IPO GMP today or grey market premium, and the Latest GMP Data is available here.
- Price Band of Sai Parenteral's IPO is ₹372 to ₹392 per share.
- Current GMP (Grey Market Premium) for Sai Parenteral's IPO is:
- It is a premium for the Sai Parenteral's IPO cut-off price .
- As per Sai Parenteral's IPO Taday’s GMP Data, the estimated listing price per shares can be:
- Estimated listing price calculated as IPO cutoff price or allotment price: + IPO current GMP: .
Sai Parenteral's IPO GMP |
||
| Date | GMP (₹) | Listing Price (₹-Estimated) |
| Today | 0 | |
| 24 March 2026 | 0 | |
| 23 March 2026 | 0 | |
| 22 March 2026 | 0 | |
| 21 March 2026 | 0 | |
| 20 March 2026 | 0 | |
Sai Parenteral's IPO will open for subscription on 24 March 2026 and close on 27 March 2026. Basis of allotment will be decided on 30 March 2026, initiation of refund will begin on 1 April 2026 and IPO will be listed on 2 April 2026 at NSE, BSE. Arihant Capital Markets Ltd is the book running lead manager and is the registrar of the IPO.
Total shares offered by Sai Parenteral's IPO is 1,04,28,288 shares (aggregating up to 408 crore 78 lakh 88 thousand 8 hundred ninety-six rupees). Out of which is reserved for retail, 15,64,243 shares (15.00%) is reserved for HNI (NII), 52,14,144 shares (50.00%) is reserved for QIB.
Sai Parenteral's IPO Price Band and Market Lot
Sai Parenteral's has set a price band of ₹372 to ₹392 per share and lot size is of 38. Retail investors can bid for a minimum of 1 lots (38 shares), requiring minimum investment of ₹14,896, and maximun upto 13 lots (494 shares), requiring maximum investment of ₹1,93,648. Small HNI investors can bid for a minimum of 14 lots (532 shares), requiring an investment of ₹2,08,544, small hni (shni) investors can bid for a maximum of 67 lots (2,546 shares), requiring an investment of ₹9,98,032 and big hni (bHNI) investors can bid for a minimum of 68 Lots (2,584 shares), requiring an investment of ₹10,12,928. Calculated at the cut-off price ₹392 per share (the upper end of the price band).
| IPO Price | |
| Face Value | ₹5 per share |
| Price Band | ₹372 to ₹392 per share |
| Lot Size | 38 shares |
About Sai Parenteral's
Incorporated in 2001, Sai Parenteral’s Limited is a Hyderabad based diversified pharmaceutical formulations company with over three decades of expertise in research, development, and manufacturing. It operates across two key verticals branded generic formulations and Contract Development & Manufacturing Organisation (CDMO) services covering therapeutic areas like cardiovascular, neuropsychiatry, anti-diabetic, respiratory, antibiotics, gastroenterology, vitamins/minerals/supplements, analgesics, and dermatology.Sai Parenteral's IPO GMP FAQs
The latest Grey Market Premium (GMP) of Sai Parenteral's IPO is .
It is a premium to the IPO cut-off price Sai Parenteral's. GMP gives a rough estimate of the premium at which the stock might list. It’s not guaranteed but often aligns with market sentiment.
As per latest GMP data, the expected return for Sai Parenteral's IPO can be .
Expected listing listing price for Sai Parenteral's share can be .
According to latest GMP data pattern expected listing price and profit per share for Sai Parenteral's IPO can be . Expected listing price is calculated by adding the GMP to the IPO issue price. Estimated listing price = IPO issue price + current GMP. This value changes as the GMP fluctuates.
GMP is an unofficial indicator and can be manipulated. It should never be the sole reason to apply. Always consider Sai Parenteral's fundamentals and your risk tolerance. Subscription demand, financial performance, market sentiment, peer valuation, and overall liquidity can impact the GMP trend.
Disclaimer:
- Grey market premium (GMP) indicates investors are willing to pay more than the issue price.
- A negative GMP suggests that the IPO’s share is likely to be listed on the stock exchange at a discount, and a positive Grey Market Premium suggests that the IPO’s share is likely to be listed on the stock exchange at a profit.
- Do not subscribe for IPO by just seeing the premium Price, It can change anytime
- We do not trade/deal or buy/sell IPO forms in the grey market and GMP prices shown here are gathered from various sources.